ARS Pharmaceuticals, Inc. (SPRY)

Typically moves ±5.56% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-10 APPROXIMATE

Since Mar 29, 2021, ARS Pharmaceuticals, Inc. (SPRY) has reported earnings 20 times. On average the shares move ±5.56% post-earnings, with a positive reaction 30.0% of the time. Its largest post-earnings gain was +22.83% (Mar 20, 2025) and its largest decline was -15.23% (Nov 13, 2024). The next earnings report is predicted for 2026-08-10 (approximate).

Earnings reactions

How SPRY moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.56%

Positive %

30.0%

Negative %

70.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 15, 2026	☀ PRE	-6.43%	open_in_new
Mar 09, 2026	☀ PRE	-0.11%	open_in_new
Nov 10, 2025	☀ PRE	+0.34%	open_in_new
Aug 13, 2025	☀ PRE	-5.04%	open_in_new
May 14, 2025	☀ PRE	-9.36%	open_in_new
Mar 20, 2025	☀ PRE	+22.83%	open_in_new
Nov 13, 2024	☀ PRE	-15.23%	open_in_new
Aug 06, 2024	☽ POST	-2.2%	open_in_new
May 09, 2024	☽ POST	-0.68%	open_in_new
Mar 21, 2024	☽ POST	-3.89%	open_in_new
Nov 09, 2023	☽ POST	+8.75%	open_in_new
Aug 10, 2023	☽ POST	-0.29%	open_in_new
May 15, 2023	☀ PRE	-2.86%	open_in_new
Mar 23, 2023	☽ POST	-4.05%	open_in_new
May 12, 2022	☽ POST	-2.31%	open_in_new
Mar 31, 2022	☽ POST	-8.55%	open_in_new
Nov 10, 2021	☽ POST	+2.31%	open_in_new
Aug 12, 2021	☽ POST	+3.09%	open_in_new
May 13, 2021	☽ POST	+7.32%	open_in_new
Mar 29, 2021	☽ POST	-5.65%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.56%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 18 →

Funds holding

$117731329

Total value held

Buying

11 added · 7 reduced

Blackrock, Inc.

$40248399 -1.44%

State Street Corp

$29269077 +13.07%

Franklin Resources Inc

$26326745 +28.92%

Goldman Sachs Group Inc

$5815478 -10.81%

Northern Trust Corp

$4250150 +1.59%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260717	open_in_new SEC.gov
SCHEDULE 13G/A	20260714	open_in_new SEC.gov
8-K	20260707	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov

Frequently asked about SPRY earnings

When does ARS Pharmaceuticals, Inc. report earnings next? expand_more

ARS Pharmaceuticals, Inc. (SPRY)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does SPRY stock move after earnings? expand_more

Over 20 reports, SPRY has moved an average of ±5.56% the session after earnings, closing higher 30.0% of the time.

What was SPRY's biggest post-earnings move? expand_more

SPRY's largest post-earnings gain on record was +22.83% on Mar 20, 2025, and its largest decline was -15.23% on Nov 13, 2024.

Where can I find ARS Pharmaceuticals, Inc.'s SEC filings? expand_more

All of ARS Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.